Literature DB >> 22148589

A structure-based approach to understanding somatostatin receptor-4 agonism (sst4).

Zhaomin Liu1, A Michael Crider, Daniel Ansbro, Christina Hayes, Maria Kontoyianni.   

Abstract

It has been reported that somatostatin receptor subtypes 4 and 5 would be high-impact templates for homology modeling if their 3D structures became available. We have generated a homology model of the somatostatin receptor subtype 4 (sst4), using the newest active state β(2) adrenoreceptor crystal structure, and subsequently docked a variety of agonists into the model-built receptor to elucidate the binding modes of reported agonists. Using experimental restraints, we were able to explain observed activity profiles. We propose two binding modes that can consistently explain findings for high-affinity agonists and reason why certain structures display low affinities for the receptor.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22148589     DOI: 10.1021/ci200375j

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  7 in total

1.  Treating pain with somatostatin receptor subtype 4 agonists.

Authors:  Ahmed F Abdel-Magid
Journal:  ACS Med Chem Lett       Date:  2015-01-08       Impact factor: 4.345

Review 2.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

3.  Synthesis and structure-activity relationships of 3,4,5-trisubstituted-1,2,4-triazoles: high affinity and selective somatostatin receptor-4 agonists for Alzheimer's disease treatment.

Authors:  William L Neumann; Karin E Sandoval; Shirin Mobayen; Mahsa Minaeian; Stephen G Kukielski; Khush N Srabony; Rafael Frare; Olivia Slater; Susan A Farr; Michael L Niehoff; Audrey Hospital; Maria Kontoyianni; A Michael Crider; Ken A Witt
Journal:  RSC Med Chem       Date:  2021-05-26

4.  In Silico, In Vitro and In Vivo Pharmacodynamic Characterization of Novel Analgesic Drug Candidate Somatostatin SST4 Receptor Agonists.

Authors:  Boglárka Kántás; Éva Szőke; Rita Börzsei; Péter Bánhegyi; Junaid Asghar; Lina Hudhud; Anita Steib; Ágnes Hunyady; Ádám Horváth; Angéla Kecskés; Éva Borbély; Csaba Hetényi; Gábor Pethő; Erika Pintér; Zsuzsanna Helyes
Journal:  Front Pharmacol       Date:  2021-01-27       Impact factor: 5.810

5.  Exploration of Somatostatin Binding Mechanism to Somatostatin Receptor Subtype 4.

Authors:  Rita Börzsei; Balázs Zoltán Zsidó; Mónika Bálint; Zsuzsanna Helyes; Erika Pintér; Csaba Hetényi
Journal:  Int J Mol Sci       Date:  2022-06-21       Impact factor: 6.208

6.  Structural insights into ligand recognition and selectivity of somatostatin receptors.

Authors:  Wenli Zhao; Shuo Han; Na Qiu; Wenbo Feng; Mengjie Lu; Wenru Zhang; Mu Wang; Qingtong Zhou; Shutian Chen; Wei Xu; Juan Du; Xiaojing Chu; Cuiying Yi; Antao Dai; Liaoyuan Hu; Michelle Y Shen; Yaping Sun; Qing Zhang; Yingli Ma; Wenge Zhong; Dehua Yang; Ming-Wei Wang; Beili Wu; Qiang Zhao
Journal:  Cell Res       Date:  2022-06-23       Impact factor: 46.297

7.  Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain.

Authors:  Boglárka Kántás; Rita Börzsei; Éva Szőke; Péter Bánhegyi; Ádám Horváth; Ágnes Hunyady; Éva Borbély; Csaba Hetényi; Erika Pintér; Zsuzsanna Helyes
Journal:  Int J Mol Sci       Date:  2019-12-11       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.